111 results
8-K
LSTA
Lisata Therapeutics Inc
14 Jun 23
Submission of Matters to a Vote of Security Holders
5:05pm
basis, the executive compensation of the Company's named executive officers as disclosed in the Proxy Statement. The final voting results with respect
8-K
qilai2h
14 Sep 22
Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata Therapeutics
5:01pm
425
x26ksynch1rn97mt9
2 Sep 22
Business combination disclosure
4:01pm
424B3
rffj6tj m15t9cy15
29 Jul 22
Prospectus supplement
4:06pm
8-K
EX-2.1
w473 p8lr8ekxuc8nre
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
tdwpxt1
16 Jun 21
Submission of Matters to a Vote of Security Holders
4:20pm